What is the effect of Lysoveta DHA-LPC for APOE4 carriers?
Phoenix has measured Lysoveta DHA-LPC against 1 exact outcome for APOE4 carriers. Member #1EB8E9's Triglycerides moved from 81 to 52.3 mg/dL in 106 days.
One intervention, every measured benefit and result that did not improve. See who it moved for, where it stayed neutral or went the other way, and the next hypothesis Phoenix can validate.
Phoenix APOE4 Research · Reviewed by Kevin Tran, APOE4/4 carrier and founder · Data through 2026-08-23 · How to read this research
How to read this
Observational research: real APOE4 carriers tracked over time, each compared with their own earlier self. Members chose their interventions, with no randomisation or placebo group. Everything else they changed is shown beside each result.
Read the full methods and limitsPhoenix has measured Lysoveta DHA-LPC against 1 exact outcome for APOE4 carriers. Member #1EB8E9's Triglycerides moved from 81 to 52.3 mg/dL in 106 days.
| Outcome | Direction | What we observed |
|---|---|---|
| Triglycerides | Positive individual result | Member #1EB8E9's Triglycerides moved from 81 to 52.3 mg/dL in 106 days. |
Phoenix has measured Lysoveta DHA-LPC against 1 exact outcome for APOE4 carriers. Member #1EB8E9's Triglycerides moved from 81 to 52.3 mg/dL in 106 days.
Member #1EB8E9's Triglycerides moved from 81 to 52.3 mg/dL in 106 days. Support: 1 logged members, 1 members with repeats, 1 observations, 2 measurements.
Search by health goal or intervention to see what changed for real members, including results that moved the wrong way.
Lysoveta DHA-LPC · 1 outcome shown.
Triglycerides: Decrease 28.7 mg/dL
Cases: 1
Member #1EB8E9's Triglycerides moved from 81 to 52.3 mg/dL in 106 days.
Lysoveta DHA-LPC
✓Positive individual resultMember #1EB8E9's Triglycerides moved from 81 to 52.3 mg/dL in 106 days.
Triglycerides
Before81After52.3mg/dL-35.4%
106 days between measurements
Full stack credited: Lysoveta (DHA-LPC) (lead), Curcumin (co), Nicotinamide riboside (co).
What else changed: no nearby starts were recorded.
Next study: repeat Triglycerides after a dated Lysoveta DHA-LPC window.
The 43-page study: what members tried, how their bloodwork and wearable results changed, and what else changed alongside them.
Turn evidence into your next test
476 members have already tried, measured and logged. Join Phoenix and your next blood draw joins the same Navigator you are reading.
Full research index
Choose an outcome, like LDL cholesterol or sleep, or an intervention, like training: both paths open the same measured records.